Seeking AlphaCodex · 实盘不做把握 8/10
北京时间·🕒 发布 22:28:08时区推断·⟳ 抓取 22:28:14·⚡ 决策 07-29 22:28:47 +33s·90.1 天前
再生元将于7月30日盘前公布二季度业绩，当前仅为财报前瞻
这条信号只是Seeking Alpha对再生元（REGN.US）即将公布Q2财报的日程和一致预期汇总，没有披露实际业绩、指引或超预期信息。
📄 原文Seeking Alpha↗ 原文
Regeneron Pharmaceuticals Q2 2026 Earnings Preview
- Regeneron Pharmaceuticals (REGN) is scheduled to announce Q2 earnings results on Thursday, July 30th, before market o…
不做 再生元（REGN.US）
仅为财报前瞻和一致预期汇总，没有实际业绩、指引或超预期增量；需等7月30日盘前正式财报后由新信号研判。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-29 · 扩散 medium · price-in 风险 high ↗
关键理由
- 这条信号只是Seeking Alpha对再生元（REGN.US）即将公布Q2财报的日程和一致预期汇总，没有披露实际业绩、指引或超预期信息。
- EPS和收入一致预期、过去beat比例、分析师上修/下修数量均属于财报前已知背景，不能构成当前时点的同向交易催化。
主要风险
- 真正可交易的信息需等7月30日盘前实际业绩、指引和管理层口径相对一致预期的偏离。
原文全文
展开原文 · 504 字
- Regeneron Pharmaceuticals (REGN) is scheduled to announce Q2 earnings results on Thursday, July 30th, before market open.
- The consensus EPS estimate is $10.20 (-20.9% Y/Y) and the consensus revenue estimate is $3.83B (+4.1% Y/Y).
- Over the last 2 years, REGN has beaten EPS estimates 88% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 4 upward revisions and 17 downward. Revenue estimates have seen 7 upward revisions and 10 downward.
- The consensus EPS estimate is $10.20 (-20.9% Y/Y) and the consensus revenue estimate is $3.83B (+4.1% Y/Y).
- Over the last 2 years, REGN has beaten EPS estimates 88% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 4 upward revisions and 17 downward. Revenue estimates have seen 7 upward revisions and 10 downward.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。